Category: News
-
UCSC engineer played crucial role in 2022 Nobel Prize-winning research
Biomolecular engineering’s Richard (Ed) Green collaborated with medalist Svante Pääbo’s research on the Neanderthal genome Emily Cerf | UCSC | October 11, 2022 The 2022 Nobel Prize in Physiology or Medicine was awarded to Swedish geneticist Svante Pääbo for his research on human evolution, specifically in using contemporary tools to sequence and compare the genomes…
-
New Educational Module for UCSC Genome Browser
In response to requests from users, we are announcing a new education module in the UCSC Genome Browser training pages. The UCSC Genome Browser is our most widely used genomics tool. Tens of thousands of researchers access it each year to view all 23 chromosomes of the human genome, down to its individual nucleotides. It…
-
Carol Greider honored by the Association for Molecular Pathology (AMP)
UC Santa Cruz genomics institute affiliate Carol Greider is being honored by the Association for Molecular Pathology (AMP) for her pioneering work in telomere research and its impact on the field of molecular diagnostics.
-
New program will mentor and train students underrepresented in genomics research
The UC Santa Cruz Genomics Institute will partner with California State University, Monterey Bay (CSUMB) and the University of Puerto Rico, Río Piedras (UPRRP) Campus to mentor and provide genomics research experience for students from these two hispanic-serving institutions…
-
Childhood Cancer Awareness Month Researcher Profiles: Molly McCabe
“Cancer has impacted me deeply. I lost my mother to melanoma when I was 13 years old, and my now-14-year-old brother is 10 years Medulloblastoma free. Working for the Treehouse Childhood Cancer Initiative, Olena Vaske, and Anouk van den Bout has allowed me to understand the disease further, and made me feel like I am…
-
Large Scientific Collaborations Aim to Complete Human Genome
Jordan Eizenga is a postdoc at the UC Santa Cruz Genomics Institute and writes about the shortcomings of the current human genome reference and what the Human Pangenome Reference Consortium is doing to fix them. Read in The Scientist
-
From concept to commercialization: How UCSC researchers revolutionized DNA sequencing
Nanopore sequencing technology, which has dramatically lowered the cost and increased the accuracy of genomic sequencing over the last two decades, was first patented and developed at UC Santa Cruz. Its inventors reflect on its history, as well as its seemingly unlimited potential for advancing personalized medicine and our understanding of our world.
-
Help our CALeDNA efforts: Become a citizen scientist
Julia Paskin | LAist | July 25, 2022 Researchers want your help to collect samples at four specific locations in Los Angeles as part of a much wider effort in the state to learn about changes in biodiversity. The project, called CALeDNA, for California Environmental DNA, encourages everyone to be a citizen scientist. Volunteers get a kit to…
-
Steve Kang celebrates a career of seizing challenges
(Kang at the 2022 ISCAS Conference in Texas.) Emily Cerf | UCSC | July 25, 2022 As the first in his family to graduate college and in taking on positions as the second dean of the Baskin School of Engineering and chancellor of UC Merced, Sung-Mo “Steve” Kang has always been someone ready and willing…
-
Genomics Institute affiliates discuss importance of reference genomes for conservation
UCSC | July 21, 2022 As of 2022, the International Union for Conservation of Nature (IUCN) Red List estimates that more than 32% of fungal, plant, and animal species are threatened with extinction. This sixth mass extinction is caused by the activities and expanding biomass of humans, necessitating a distinct name for this geological epoch—the…
-
Working Toward a ‘Holy Grail’ Blood Test to Diagnose Cancer Years Before Symptoms
UCSC | July, 2022 Researchers in the Daniel Kim lab have discovered previously unknown biomarkers that are released from RNA in the very early stages of cancer. This discovery could lead to the development of tests to measure for these biomarkers in healthy-seeming patients. Detecting cancer earlier, when it is easier to treat, could save…
